Tenet Healthcare Corporation (THC) Stock Score, Valuation & Financial Research
Tenet Healthcare Corporation is in the Healthcare sector and Medical - Care Facilities industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 45/100.
Quick answer for THC
Tenet Healthcare Corporation currently has a Wall Street Score of 45/100. The stored market price is $263.69. Its financial score is 29/100. Its valuation score is 22/100. These figures are a research snapshot, not a buy or sell recommendation.
What Tenet Healthcare Corporation does
Tenet Healthcare Corporation operates as a broad-ranging provider of health solutions. The company organizes its operations across three main divisions: Hospital Operations and Other, Ambulatory Care, and Conifer. Within its network of acute care facilities, Tenet delivers a full spectrum of essential services. These include core hospital functions such as operating and recovery suites, radiology and respiratory therapy, clinical laboratories, and on-site pharmacies. The organization also provides high-acuity patient care through intensive, critical, and coronary care units. Specialized medical services cover areas like cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics, alongside various outpatient treatments, including physical therapy. Advanced surgical capabilities feature cardiothoracic, complex spinal, and neurosurgery, as well as neonatal intensive c
THC financial snapshot
- Wall Street Score:
- 45/100
- Current price:
- $263.69
- Market capitalization:
- $21.23B
- Revenue:
- $21.45B
- Net income:
- $1.70B
- Free cash flow:
- $2.53B
- Cash:
- $2.17B
- Total debt:
- $160.0M
- EPS:
- 15.61
- P/E ratio:
- 16.9x
- Financial score:
- 29/100
- Valuation score:
- 22/100
- Revenue score:
- 28/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $2.53B, showing positive cash generation.
- The balance sheet shows $2.17B of cash versus $160.0M of total debt, leaving more cash than debt.
What the numbers mean
Its current valuation score is 22/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 29/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research THC
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.